ストックスクリーナーアプリを入手
71.24
1.41%
0.99
アフターアワーズ：
70.70
-0.54
-0.76%
前日終値:
$70.25
開ける：
$70.42
24時間の取引高:
4.64M
Relative Volume:
0.80
時価総額：
$220.92B
収益：
$51.21B
当期純損益:
$6.50B
株価収益率:
34.17
EPS:
2.085
ネットキャッシュフロー:
$6.76B
1週間 パフォーマンス:
+3.85%
1か月 パフォーマンス:
+8.65%
6か月 パフォーマンス:
-8.55%
1年 パフォーマンス:
+6.01%
1日の値動き範囲:
$70.32
$71.44
1週間の範囲:
$68.84
$71.44
52週間の値動き範囲:
$60.47
$87.67
Astrazeneca PLC Stock (AZN) Company Profile
名前
Astrazeneca PLC
セクター
電話
44 20 3749 5000
住所
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge
AZN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AZN
Astrazeneca PLC
|
71.24 | 220.92B | 51.21B | 6.50B | 6.76B | 2.085 |
Astrazeneca PLC Stock (AZN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-20 | アップグレード | UBS | Sell → Neutral |
| 2024-11-06 | アップグレード | Deutsche Bank | Sell → Hold |
| 2024-09-13 | ダウングレード | Deutsche Bank | Hold → Sell |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2024-04-16 | アップグレード | Deutsche Bank | Sell → Hold |
| 2024-02-08 | ダウングレード | Deutsche Bank | Hold → Sell |
| 2024-01-23 | 開始されました | Morgan Stanley | Overweight |
| 2024-01-16 | 再開されました | UBS | Sell |
| 2024-01-03 | ダウングレード | Jefferies | Buy → Hold |
| 2023-12-18 | 開始されました | HSBC Securities | Buy |
| 2023-09-25 | アップグレード | Jefferies | Hold → Buy |
| 2023-07-14 | 開始されました | HSBC Securities | Buy |
| 2023-07-12 | アップグレード | UBS | Neutral → Buy |
| 2023-07-05 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2023-04-11 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-01-05 | 開始されました | BMO Capital Markets | Outperform |
| 2022-09-15 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2022-09-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-29 | アップグレード | Argus | Hold → Buy |
| 2022-06-14 | ダウングレード | UBS | Buy → Neutral |
| 2022-02-11 | アップグレード | DZ Bank | Sell → Hold |
| 2021-12-07 | ダウングレード | Jefferies | Buy → Hold |
| 2021-08-12 | 再開されました | JP Morgan | Overweight |
| 2021-04-12 | ダウングレード | Argus | Buy → Hold |
| 2021-03-16 | アップグレード | Jefferies | Hold → Buy |
| 2021-02-25 | アップグレード | UBS | Neutral → Buy |
| 2021-01-15 | 開始されました | Deutsche Bank | Buy |
| 2020-12-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-30 | アップグレード | UBS | Sell → Neutral |
| 2020-11-11 | アップグレード | HSBC Securities | Reduce → Hold |
| 2020-09-29 | 開始されました | Berenberg | Buy |
| 2019-11-22 | 開始されました | SVB Leerink | Outperform |
| 2019-10-25 | アップグレード | Liberum | Hold → Buy |
| 2019-04-02 | ダウングレード | UBS | Neutral → Sell |
| 2019-02-05 | 開始されました | Exane BNP Paribas | Outperform |
| 2019-01-25 | アップグレード | Shore Capital | Hold → Buy |
| 2018-12-11 | 再開されました | Jefferies | Hold |
| 2018-10-09 | 開始されました | Guggenheim | Buy |
| 2018-08-16 | ダウングレード | Jefferies | Buy → Hold |
| 2018-03-19 | アップグレード | Jefferies | Hold → Buy |
| 2018-02-06 | 繰り返されました | Leerink Partners | Mkt Perform |
| 2018-02-05 | 繰り返されました | Bernstein | Outperform |
| 2018-01-18 | 繰り返されました | Leerink Partners | Mkt Perform |
| 2017-12-29 | アップグレード | JP Morgan | Neutral → Overweight |
| 2017-10-16 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2017-09-25 | アップグレード | Exane BNP Paribas | Neutral → Outperform |
| 2017-09-22 | アップグレード | Bernstein | Mkt Perform → Outperform |
すべてを表示
Astrazeneca PLC (AZN) 最新ニュース
ROSEN, THE FIRST FILING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AZN - GlobeNewswire Inc.
AstraZeneca PLC ADR underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Shareholders that lost money on AstraZeneca PLC(AZN) should - GlobeNewswire
Deadline Alert: AstraZeneca PLC (AZN) Investors Who Lost - GlobeNewswire
AstraZeneca and GSK put spotlight on pharma as results loom - Proactive Investors UK
Investors in AstraZeneca PLC Should Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your RightsAZN - Stockhouse Publishing
AZN LAWSUIT ALERT: The Gross Law Firm Notifies AstraZeneca PLC Investors of a Class Action Lawsuit and Upcoming Deadline - PR Newswire
AstraZeneca (AZN) to Release Quarterly Earnings on Thursday - MarketBeat
2025-01-29 | Shareholders that lost money on AstraZeneca PLC (AZN) should contact Levi & Korsinsky about pending Class ActionAZN | NDAQ:AZN | Press Release - Stockhouse Publishing
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
AstraZeneca's SWOT analysis: pharma giant's stock poised for growth amid challenges - Investing.com
Class Action Filed Against AstraZeneca PLC (AZN)February 21, 2025 Deadline to JoinContact Levi & Korsinsky - Stockhouse Publishing
Levi & Korsinsky Notifies AstraZeneca PLC Investors of a Class Action Lawsuit and Upcoming DeadlineAZN - Stockhouse Publishing
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca - GlobeNewswire
Should AstraZeneca Stock Be in Your Portfolio Pre-Q4 Earnings? - Yahoo Finance
Swedbank AB Purchases 125,600 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Lost Money on AstraZeneca PLC(AZN)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - Stockhouse Publishing
Iams Wealth Management LLC Increases Stake in AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Here's Why Astrazeneca (AZN) is a Strong Value Stock - Yahoo Finance
Orca Wealth Management LLC Invests $4.53 Million in AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Russ Mould: what to expect when AstraZeneca and GSK report next week - AJ Bell
AstraZeneca's (AZN) "Buy" Rating Reaffirmed at Berenberg Bank - MarketBeat
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming DeadlinesAZN - PR Newswire
Global markets live: Nvidia, Microsoft, Lockheed Martin, AstraZeneca, Airbus… - Marketscreener.com
FDA Approves AstraZeneca, Daiichi Sankyo's Enhertu For Certain Type Of Breast Cancer Patients - Benzinga
AZN Investors Have Opportunity to Lead AstraZeneca PLC Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Shareholders of AstraZeneca PLC Should Contact The Gross Law Firm Before February 21, 2025 to Discuss Your RightsAZN - The Malaysian Reserve
AstraZeneca Scores US Regulatory Approval for Breast Cancer Treatment Enhertu -January 28, 2025 at 06:01 am EST - Marketscreener.com
Blue Trust Inc. Buys 7,686 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
AstraZeneca: FDA extends approval of Enhertu -January 28, 2025 at 04:32 am EST - Marketscreener.com
Dynamic Advisor Solutions LLC Cuts Stake in AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
AstraZeneca, Daiichi’s Drug Wins Wider Use in Breast Cancer Patients - Bloomberg
ROSEN, THE FIRST FILING FIRM, Encourages AstraZeneca PLC - GlobeNewswire
AstraZeneca, Daiichi Sankyo's Breast Cancer Treatment Wins US Approval -January 27, 2025 at 11:18 pm EST - Marketscreener.com
Chronic Pulmonary Infections Pipeline 2024: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Teva Pharma, Merck, F. Hoffmann-La Roche, Novartis, GlaxoSmithKline, AstraZeneca - The Globe and Mail
AstraZeneca PLC ADR rises Monday, outperforms market - MarketWatch
AstraZeneca rises Monday, outperforms market - MarketWatch
2025-01-27 | AstraZeneca PLC Sued for Securities Law ViolationsContact Levi & Korsinsky Before February 21, 2025 to Discuss Your RightsAZN | NDAQ:AZN | Press Release - Stockhouse Publishing
AZN Investors Have Opportunity to Lead AstraZeneca PLC Securities Fraud Lawsuit Filed by The Rosen Law Firm - PR Newswire
2025-01-26 | AstraZeneca PLC Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your RightsAZN | NDAQ:AZN | Press Release - Stockhouse Publishing
AstraZeneca PLC (NASDAQ:AZN) Shares Acquired by Asio Capital LLC - MarketBeat
AstraZeneca - Britannica
Goelzer Investment Management Inc. Buys 22,983 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Encompass More Asset Management Makes New $314,000 Investment in AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Dakota Wealth Management Sells 6,806 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Class Action Filed Against AstraZeneca PLC (AZN) Seeking Recover - GuruFocus.com
ROSEN, THE FIRST FILING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before - The Bakersfield Californian
AstraZeneca PLC's (LON:AZN) Popularity With Investors Is Clear - Simply Wall St
AstraZeneca Canadian investment to drive R&D growth -January 24, 2025 at 12:01 pm EST - Marketscreener.com
AstraZeneca rises Friday, outperforms market - MarketWatch
Lowey Dannenberg Notifies AstraZeneca PLC (“AstraZeneca” or - GlobeNewswire
Astrazeneca PLC (AZN) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):